OncoRay, National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany.
Institute for Pathology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Mol Cancer Res. 2019 Oct;17(10):2126-2138. doi: 10.1158/1541-7786.MCR-18-1352. Epub 2019 Jul 23.
Pancreatic ductal adenocarcinoma (PDAC) stroma, composed of extracellular matrix (ECM) proteins, promotes therapy resistance and poor survival rate. Integrin-mediated cell/ECM interactions are well known to control cancer cell survival, proliferation, and therapy resistance. Here, we identified β8 integrin in a high-throughput knockdown screen in three-dimensional (3D), ECM-based cell cultures for novel focal adhesion protein targets as a critical determinant of PDAC cell radiochemoresistance. Intriguingly, β8 integrin localizes with the golgi apparatus perinuclearly in PDAC cells and resection specimen from PDAC patients. Upon radiogenic genotoxic injury, β8 integrin shows a microtubule-dependent perinuclear-to-cytoplasmic shift as well as strong changes in its proteomic interactome regarding the cell functions transport, catalysis, and binding. Parts of this interactome link β8 integrin to autophagy, which is diminished in the absence of β8 integrin. Collectively, our data reveal β8 integrin to critically coregulate PDAC cell radiochemoresistance, intracellular vesicle trafficking, and autophagy upon irradiation. IMPLICATIONS: This study identified β8 integrin as an essential determinant of PDAC cell radiochemosensitivity and as a novel potential cancer target.
胰腺导管腺癌 (PDAC) 基质由细胞外基质 (ECM) 蛋白组成,可促进治疗耐药和生存率低。整合素介导的细胞/ECM 相互作用已被广泛认为可控制癌细胞的存活、增殖和治疗耐药性。在这里,我们在基于三维 (3D) ECM 的细胞培养物中的高通量敲低筛选中鉴定出 β8 整合素,作为 PDAC 细胞放化疗耐药的新焦点粘附蛋白靶标中的关键决定因素。有趣的是,β8 整合素在 PDAC 细胞和 PDAC 患者的切除标本中与核周高尔基器一起定位。在放射诱导的遗传毒性损伤后,β8 整合素显示出微管依赖性核周到细胞质的转移,以及其在细胞功能运输、催化和结合方面的蛋白质组相互作用体发生强烈变化。该相互作用体的一部分将β8 整合素与自噬联系起来,而自噬在缺乏β8 整合素时会减少。总的来说,我们的数据表明β8 整合素在照射后对 PDAC 细胞放化疗耐药性、细胞内囊泡运输和自噬的核心调控至关重要。
本研究鉴定出β8 整合素是 PDAC 细胞放化疗敏感性的重要决定因素,也是一种新的潜在癌症靶点。